Related Experiment Videos
Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis
Burton E Sobel1, Douglas J Taatjes, David J Schneider
1Department of Medicine, University of Vermont, Burlington, USA. Burt.sobel@vtmednet.org
Insights
Altered plasminogen activator inhibitor type-1 (PAI-1) expression in blood vessels may impact coronary artery disease development. Increased PAI-1 may worsen blood vessel disease by promoting clots and hindering cell repair, potentially increasing plaque vulnerability.
Area of Science:
- Cardiovascular biology
- Vascular pathology
- Atherosclerosis research
Background:
- Plasminogen activator inhibitor type-1 (PAI-1) is a key regulator of the fibrinolytic system.
- Dysregulation of PAI-1 expression is implicated in various cardiovascular diseases.
Purpose of the Study:
- To review the role of altered PAI-1 expression in vessel walls on coronary atherogenesis.
- To elucidate the mechanisms by which PAI-1 influences vasculopathy and plaque stability.
Main Methods:
- Literature review of studies investigating PAI-1 expression in vascular tissues.
- Analysis of the functional consequences of PAI-1 dysregulation on cellular processes relevant to atherogenesis.
Main Results:
- Altered PAI-1 expression in vessel walls is a potential factor in coronary atherogenesis.
- Upregulated PAI-1 may exacerbate vasculopathy by promoting thrombosis.
- Inhibition of vascular smooth muscle cell migration by PAI-1 can attenuate fibrous cap thickness, impacting atheroma vulnerability.
Conclusions:
- PAI-1 expression levels in vessel walls are critically linked to the development and progression of coronary atherosclerosis.
- Targeting PAI-1 may offer therapeutic strategies for managing atheroma vulnerability and preventing rupture.
Abstract:
Altered expression of plasminogen activator inhibitor type-1 in vessel walls, reviewed here, might affect coronary atherogenesis. Upregulation might exacerbate vasculopathy by potentiating thrombosis and by inhibiting vascular smooth muscle cell migration, resulting in attenuation of thickness of elaborated fibrous caps implicated in the vulnerability of atheroma to rupture.